Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Margaret Lee, PhD
Zalicus
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
48 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Buenos Aires, Buenos Aires, Argentina
- Facility name not stated
Rosario, Santa Fe Province, Argentina
- Facility name not stated
San Jan, Argentina
- Facility name not stated
San Miguel de Tucumán, Argentina
- Facility name not stated
Winnipeg, Manitoba, Canada
- Facility name not stated
St. John's, Newfoundland and Labrador, Canada
- Facility name not stated
Hamilton, Ontario, Canada
- Facility name not stated
Windsor, Ontario, Canada
- Facility name not stated
Tallinn, Estonia
- Facility name not stated
Tartu, Estonia
- Facility name not stated
Békéscsaba, Hungary
- Facility name not stated
Esztergom, Hungary
- Facility name not stated
Szolnok, Hungary
- Facility name not stated
Kaunas, Lithuania
- Facility name not stated
Vilnius, Lithuania
- Facility name not stated
Aguascalientes, Aguascalientes, Mexico
- Facility name not stated
Vallarta Norte, Guadalajara, Mexico
- Facility name not stated
Bialystok, Poland
- Facility name not stated
Elblag, Poland
- Facility name not stated
Katowice, Poland
- Facility name not stated
Krakow, Poland
- Facility name not stated
Lublin, Poland
- Facility name not stated
Poznan, Poland
- Facility name not stated
Torun, Poland
- Facility name not stated
Warsaw, Poland
- Facility name not stated
Bucharest, Romania
- Facility name not stated
Cluj-Napoca, Romania
- Facility name not stated
Timișoara, Romania
- Facility name not stated
Moscow, Russia
- Facility name not stated
Saint Petersburg, Russia
- Facility name not stated
Belgrade, Serbia
- Facility name not stated
Niška Banja, Serbia
- Facility name not stated
Pretoria, Gauteng, South Africa
- Facility name not stated
Cape Town, Western Cape, South Africa
- Facility name not stated
Worcester, Western Cape, South Africa
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Huntsville, Alabama, United States
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Little Rock, Arkansas, United States
- Facility name not stated
Anaheim, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2007
- Primary completion
- 30 Nov 2008
- Completion
- 31 Jan 2009
- Last update posted
- 29 Apr 2014
- Registered enrollment
- 51
- Registry id
- NCT00551707
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.